 | • レポートコード：D005-13164 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、組換えグリコシル化タンパク質の世界市場を広く調査・分析し、今後の市場展望をまとめております。組換えグリコシル化タンパク質の種類別市場規模（インスリン、rHGH、インターフェロン）、用途別市場規模（血液・腫瘍疾患、慢性疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis International AG、Biocon Limited、Hospira Inc、Celltrion Pharma Inc、Teva Pharmaceutical Industries Ltd ・地域別グローバル市場分析 2015年-2020年 ・組換えグリコシル化タンパク質の北米市場（アメリカ、カナダ、メキシコ） ・組換えグリコシル化タンパク質のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・組換えグリコシル化タンパク質のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・組換えグリコシル化タンパク質の南米市場（ブラジル、アルゼンチン） ・組換えグリコシル化タンパク質の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：インスリン、rHGH、インターフェロン ・用途別分析：血液・腫瘍疾患、慢性疾患、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Recombinant Glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Recombinant Glycosylated Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Recombinant Glycosylated Protein market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant Glycosylated Protein market has been segmented into
Insulin
rHGH
Interferon
By Application, Recombinant Glycosylated Protein has been segmented into:
Blood & Oncology Diseases
Chronic Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant Glycosylated Protein market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant Glycosylated Protein markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant Glycosylated Protein market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant Glycosylated Protein market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant Glycosylated Protein Market Share Analysis
Recombinant Glycosylated Protein competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant Glycosylated Protein sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant Glycosylated Protein sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant Glycosylated Protein are:
Novartis International AG
Biocon Limited
Hospira Inc
Celltrion Pharma Inc
Teva Pharmaceutical Industries Ltd
Among other players domestic and global, Recombinant Glycosylated Protein market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Glycosylated Protein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Glycosylated Protein, with price, sales, revenue and global market share of Recombinant Glycosylated Protein in 2018 and 2019.
Chapter 3, the Recombinant Glycosylated Protein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Glycosylated Protein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Recombinant Glycosylated Protein market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Recombinant Glycosylated Protein sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Recombinant Glycosylated Protein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Glycosylated Protein Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Insulin
1.2.3 rHGH
1.2.4 Interferon
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Glycosylated Protein Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood & Oncology Diseases
1.3.3 Chronic Diseases
1.3.4 Others
1.4 Overview of Global Recombinant Glycosylated Protein Market
1.4.1 Global Recombinant Glycosylated Protein Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis International AG
2.1.1 Novartis International AG Details
2.1.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis International AG SWOT Analysis
2.1.4 Novartis International AG Product and Services
2.1.5 Novartis International AG Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biocon Limited
2.2.1 Biocon Limited Details
2.2.2 Biocon Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biocon Limited SWOT Analysis
2.2.4 Biocon Limited Product and Services
2.2.5 Biocon Limited Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hospira Inc
2.3.1 Hospira Inc Details
2.3.2 Hospira Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hospira Inc SWOT Analysis
2.3.4 Hospira Inc Product and Services
2.3.5 Hospira Inc Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celltrion Pharma Inc
2.4.1 Celltrion Pharma Inc Details
2.4.2 Celltrion Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Celltrion Pharma Inc SWOT Analysis
2.4.4 Celltrion Pharma Inc Product and Services
2.4.5 Celltrion Pharma Inc Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical Industries Ltd
2.5.1 Teva Pharmaceutical Industries Ltd Details
2.5.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.5.4 Teva Pharmaceutical Industries Ltd Product and Services
2.5.5 Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Recombinant Glycosylated Protein Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Recombinant Glycosylated Protein Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Glycosylated Protein Manufacturer Market Share in 2019
3.3.2 Top 6 Recombinant Glycosylated Protein Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Recombinant Glycosylated Protein Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Glycosylated Protein Sales and Market Share by Regions (2015-2020)
4.1.2 Global Recombinant Glycosylated Protein Revenue and Market Share by Regions (2015-2020)
4.2 North America Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
4.3 Europe Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
4.5 South America Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Recombinant Glycosylated Protein Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Glycosylated Protein Sales and Market Share by Country (2015-2020)
5.1.2 North America Recombinant Glycosylated Protein Revenue and Market Share by Country (2015-2020)
5.2 United States Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
5.3 Canada Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
5.4 Mexico Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Recombinant Glycosylated Protein Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Glycosylated Protein Sales and Market Share by Country (2015-2020)
6.1.2 Europe Recombinant Glycosylated Protein Revenue and Market Share by Country (2015-2020)
6.2 Germany Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
6.3 UK Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
6.4 France Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
6.5 Russia Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
6.6 Italy Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Recombinant Glycosylated Protein Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Recombinant Glycosylated Protein Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Recombinant Glycosylated Protein Revenue and Market Share by Regions (2015-2020)
7.2 China Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
7.3 Japan Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
7.4 Korea Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
7.5 India Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
7.7 Australia Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Recombinant Glycosylated Protein Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Glycosylated Protein Sales and Market Share by Country (2015-2020)
8.1.2 South America Recombinant Glycosylated Protein Revenue and Market Share by Country (2015-2020)
8.2 Brazil Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
8.3 Argentina Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Recombinant Glycosylated Protein Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Recombinant Glycosylated Protein Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Recombinant Glycosylated Protein Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
9.3 Turkey Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
9.4 Egypt Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
9.5 South Africa Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Recombinant Glycosylated Protein Sales and Market Share by Type (2015-2020)
10.2 Global Recombinant Glycosylated Protein Revenue and Market Share by Type (2015-2020)
10.3 Global Recombinant Glycosylated Protein Price by Type (2015-2020)
11 Global Recombinant Glycosylated Protein Market Segment by Application
11.1 Global Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
11.2 Global Recombinant Glycosylated Protein Revenue Market Share by Application (2015-2020)
11.3 Global Recombinant Glycosylated Protein Price by Application (2015-2020)
12 Market Forecast
12.1 Global Recombinant Glycosylated Protein Sales, Revenue and Growth Rate (2021-2025)
12.2 Recombinant Glycosylated Protein Market Forecast by Regions (2021-2025)
12.2.1 North America Recombinant Glycosylated Protein Market Forecast (2021-2025)
12.2.2 Europe Recombinant Glycosylated Protein Market Forecast (2021-2025)
12.2.3 Asia-Pacific Recombinant Glycosylated Protein Market Forecast (2021-2025)
12.2.4 South America Recombinant Glycosylated Protein Market Forecast (2021-2025)
12.2.5 Middle East & Africa Recombinant Glycosylated Protein Market Forecast (2021-2025)
12.3 Recombinant Glycosylated Protein Market Forecast by Type (2021-2025)
12.3.1 Global Recombinant Glycosylated Protein Sales Forecast by Type (2021-2025)
12.3.2 Global Recombinant Glycosylated Protein Market Share Forecast by Type (2021-2025)
12.4 Recombinant Glycosylated Protein Market Forecast by Application (2021-2025)
12.4.1 Global Recombinant Glycosylated Protein Sales Forecast by Application (2021-2025)
12.4.2 Global Recombinant Glycosylated Protein Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Recombinant Glycosylated Protein Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Glycosylated Protein by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Glycosylated Protein Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis International AG Recombinant Glycosylated Protein Major Business
Table 9. Novartis International AG Recombinant Glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 10. Novartis International AG SWOT Analysis
Table 11. Novartis International AG Recombinant Glycosylated Protein Product and Services
Table 12. Novartis International AG Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Limited Recombinant Glycosylated Protein Major Business
Table 15. Biocon Limited Recombinant Glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 16. Biocon Limited SWOT Analysis
Table 17. Biocon Limited Recombinant Glycosylated Protein Product and Services
Table 18. Biocon Limited Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Hospira Inc Basic Information, Manufacturing Base and Competitors
Table 20. Hospira Inc Recombinant Glycosylated Protein Major Business
Table 21. Hospira Inc Recombinant Glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 22. Hospira Inc SWOT Analysis
Table 23. Hospira Inc Recombinant Glycosylated Protein Product and Services
Table 24. Hospira Inc Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Celltrion Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 26. Celltrion Pharma Inc Recombinant Glycosylated Protein Major Business
Table 27. Celltrion Pharma Inc Recombinant Glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 28. Celltrion Pharma Inc SWOT Analysis
Table 29. Celltrion Pharma Inc Recombinant Glycosylated Protein Product and Services
Table 30. Celltrion Pharma Inc Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Major Business
Table 33. Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Total Revenue (USD Million) (2018-2019)
Table 34. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 35. Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Product and Services
Table 36. Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Recombinant Glycosylated Protein Sales by Manufacturer (2018-2019) (K MT)
Table 38. Global Recombinant Glycosylated Protein Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Recombinant Glycosylated Protein Sales by Regions (2015-2020) (K MT)
Table 40. Global Recombinant Glycosylated Protein Sales Market Share by Regions (2015-2020)
Table 41. Global Recombinant Glycosylated Protein Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Recombinant Glycosylated Protein Sales by Countries (2015-2020) (K MT)
Table 43. North America Recombinant Glycosylated Protein Sales Market Share by Countries (2015-2020)
Table 44. North America Recombinant Glycosylated Protein Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Recombinant Glycosylated Protein Revenue Market Share by Countries (2015-2020)
Table 46. Europe Recombinant Glycosylated Protein Sales by Countries (2015-2020) (K MT)
Table 47. Europe Recombinant Glycosylated Protein Sales Market Share by Countries (2015-2020)
Table 48. Europe Recombinant Glycosylated Protein Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Recombinant Glycosylated Protein Sales by Regions (2015-2020) (K MT)
Table 50. Asia-Pacific Recombinant Glycosylated Protein Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Recombinant Glycosylated Protein Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Recombinant Glycosylated Protein Sales by Countries (2015-2020) (K MT)
Table 53. South America Recombinant Glycosylated Protein Sales Market Share by Countries (2015-2020)
Table 54. South America Recombinant Glycosylated Protein Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Recombinant Glycosylated Protein Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Recombinant Glycosylated Protein Sales by Countries (2015-2020) (K MT)
Table 57. Middle East & Africa Recombinant Glycosylated Protein Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Recombinant Glycosylated Protein Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Recombinant Glycosylated Protein Revenue Market Share by Countries (2015-2020)
Table 60. Global Recombinant Glycosylated Protein Sales by Type (2015-2020) (K MT)
Table 61. Global Recombinant Glycosylated Protein Sales Share by Type (2015-2020)
Table 62. Global Recombinant Glycosylated Protein Revenue by Type (2015-2020) (USD Million)
Table 63. Global Recombinant Glycosylated Protein Revenue Share by Type (2015-2020)
Table 64. Global Recombinant Glycosylated Protein Sales by Application (2015-2020) (K MT)
Table 65. Global Recombinant Glycosylated Protein Sales Share by Application (2015-2020)
Table 66. Global Recombinant Glycosylated Protein Sales Forecast by Regions (2021-2025) (K MT)
Table 67. Global Recombinant Glycosylated Protein Market Share Forecast by Regions (2021-2025)
Table 68. Global Recombinant Glycosylated Protein Sales Forecast by Type (2021-2025) (K MT)
Table 69. Global Recombinant Glycosylated Protein Market Share Forecast by Type (2021-2025)
Table 70. Global Recombinant Glycosylated Protein Sales Forecast by Application (2021-2025)
Table 71. Global Recombinant Glycosylated Protein Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Recombinant Glycosylated Protein Picture
Figure 2. Global Sales Market Share of Recombinant Glycosylated Protein by Type in 2019
Figure 3. Insulin Picture
Figure 4. rHGH Picture
Figure 5. Interferon Picture
Figure 6. Recombinant Glycosylated Protein Sales Market Share by Application in 2018
Figure 7. Blood & Oncology Diseases Picture
Figure 8. Chronic Diseases Picture
Figure 9. Others Picture
Figure 10. Global Recombinant Glycosylated Protein Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Recombinant Glycosylated Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Recombinant Glycosylated Protein Sales Market Share by Manufacturer in 2019
Figure 31. Global Recombinant Glycosylated Protein Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Recombinant Glycosylated Protein Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Recombinant Glycosylated Protein Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Recombinant Glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Recombinant Glycosylated Protein Revenue Market Share by Regions (2015-2020)
Figure 38. Global Recombinant Glycosylated Protein Revenue Market Share by Regions in 2018
Figure 39. North America Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 40. Europe Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 42. South America Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020)
Figure 44. North America Recombinant Glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Recombinant Glycosylated Protein Sales Market Share by Countries (2015-2020)
Figure 46. North America Recombinant Glycosylated Protein Sales Market Share by Countries in 2018
Figure 47. North America Recombinant Glycosylated Protein Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Recombinant Glycosylated Protein Revenue Market Share by Countries in 2018
Figure 49. United States Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Recombinant Glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Recombinant Glycosylated Protein Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Recombinant Glycosylated Protein Revenue Market Share by Countries in 2019
Figure 55. Germany Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Recombinant Glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Recombinant Glycosylated Protein Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Recombinant Glycosylated Protein Revenue Market Share by Regions 2019
Figure 63. China Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Recombinant Glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Recombinant Glycosylated Protein Sales Market Share by Countries in 2019
Figure 70. South America Recombinant Glycosylated Protein Revenue Market Share by Countries in 2019
Figure 71. Brazil Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Recombinant Glycosylated Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Recombinant Glycosylated Protein Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Recombinant Glycosylated Protein Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Recombinant Glycosylated Protein Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Recombinant Glycosylated Protein Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Recombinant Glycosylated Protein Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Recombinant Glycosylated Protein Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Recombinant Glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Recombinant Glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Recombinant Glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Recombinant Glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Recombinant Glycosylated Protein Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
組み換え非グリコシル化タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Non-glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombin…- 治療用組換えタンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Therapeutic Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant T…
- 組換えタンパク質薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Protein Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Protein…
- 組換えワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 935.1 million by 2025, from USD 822.7 million in 2019. The Recombinant Vacci…
- 組換えヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Huma…